Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death.
Delehouzé C, Comte A, Leon-Icaza SA, Cougoule C, Hauteville M, Goekjian P, Bulinski JC, Dimanche-Boitrel MT, Meunier E, Rousselot M, Bach S. Delehouzé C, et al. Among authors: hauteville m. Sci Rep. 2022 Mar 24;12(1):5118. doi: 10.1038/s41598-022-09019-w. Sci Rep. 2022. PMID: 35332201 Free PMC article.
6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury.
Delehouzé C, Leverrier-Penna S, Le Cann F, Comte A, Jacquard-Fevai M, Delalande O, Desban N, Baratte B, Gallais I, Faurez F, Bonnet MC, Hauteville M, Goekjian PG, Thuillier R, Favreau F, Vandenabeele P, Hauet T, Dimanche-Boitrel MT, Bach S. Delehouzé C, et al. Among authors: hauteville m. Sci Rep. 2017 Oct 10;7(1):12931. doi: 10.1038/s41598-017-12788-4. Sci Rep. 2017. PMID: 29018243 Free PMC article.
Predictive factors of survival after thalidomide therapy in advanced multiple myeloma: long-term follow-up of a prospective multicenter nonrandomized phase II study in 120 patients.
Decaux O, Renault A, Sébille V, Moreau P, Attal M, Voillat L, Pegourie B, Tiab M, Facon T, Zerbib R, Grosbois B, Bellissant E; Intergroupe Francophone du Myélome. Decaux O, et al. Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):418-22. doi: 10.1016/j.clml.2012.06.003. Epub 2012 Sep 29. Clin Lymphoma Myeloma Leuk. 2012. PMID: 23025991 Clinical Trial.